ENDPOINTS

Illumina confirms SEC has closed investigation into $8B Grail deal

Illumina on Thursday said the SEC has closed its investigation into the company's $8 billion purchase of Grail and doesn't intend to pursue enforcement action, confirming Endpoints News' reporting earlier this week ...

May 8, 2025 - 23:34
 0
Illumina confirms SEC has closed investigation into $8B Grail deal
Illumina on Thursday said the SEC has closed its investigation into the company's $8 billion purchase of Grail and doesn't intend to pursue enforcement action, confirming Endpoints News' reporting earlier this week ...
Read More

Tags:

Previous Article

Microgrids Could Enhance Grid Resilience

Next Article

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat...

Related Posts

Caribou lays off 32% of staff, cuts lupus program

Caribou lays off 32% of staff, cuts lupus program

Apr 24, 2025  0

Singapore cardio gene therapy biotech collects $45M as it plots Europe expansion

Singapore cardio gene therapy biotech collects $45M as ...

May 6, 2025  0

#AACR25: Revolution’s KRAS drug shows potential in early cut of lung cancer data

#AACR25: Revolution’s KRAS drug shows potential in earl...

Apr 28, 2025  0